Perspective Therapeutics, Inc. 8-K

What Happened
Perspective Therapeutics, Inc. (CATX) filed a Form 8-K on January 12, 2026 (Item 8.01) to announce that it issued a press release describing certain business updates and the company’s strategic priorities. The press release is included in the filing as Exhibit 99.1 and is incorporated by reference. The report was signed by CEO Johan (Thijs) Spoor on January 12, 2026.

Key Details

• Filing date: January 12, 2026 (Form 8-K, Item 8.01 — Other Events).
• Press release: dated January 12, 2026, filed as Exhibit 99.1 and incorporated by reference.
• Signatory: Johan (Thijs) Spoor, Chief Executive Officer, signed the 8-K.
• Exhibit disclosure also included the Inline XBRL cover page (Exhibit 104).

Why It Matters
The 8-K signals the company has provided investors updated information about its business direction and priorities; investors should read Exhibit 99.1 (the press release) for the specific operational or strategic changes. Because this filing is categorized as “Other Events,” it does not itself provide financial results or regulatory actions — monitor subsequent SEC filings or company releases for any material changes to guidance, finances, leadership, or programs.